1. Revisiting the IGF-1R as a breast cancer target
   Roudy Chiminch Ekyalongo et al, 2017, npj Precision Oncology CrossRef
2. Insulin-like growth factor binding protein-3 mediates hyperosmolar stress–induced mitophagy through the mechanistic target of rapamycin
   Whitney Stuard Sambhariya et al, 2023, Journal of Biological Chemistry CrossRef
3. MicroRNA-197 Mediates the Overgrowth and Anti-Apoptotic Effects by Downregulating Insulin-Like Growth Factor-Binding Protein-3 During Nephroblastoma Tumorigenesis
   Jinhua Hu et al, 2016, Fetal and Pediatric Pathology CrossRef
4. Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging
   Dehong Cao et al, 2022, Frontiers in Immunology CrossRef
5. Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia
   Junya Hata et al, 2023, International Journal of Molecular Sciences CrossRef
6. The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment
   Yudi Wang et al, 2024, Medical Oncology CrossRef
7. Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway
   Zhanyu Wang et al, 2017, Oncotarget CrossRef
8. Fortifying the Treatment of Prostate Cancer with Physical Activity
   Colin E. Champ et al, 2016, Prostate Cancer CrossRef
9. Intrinsic and extrinsic factors causing hyperplasia of the prostate
   Yuki Kyoda et al, 2024, International Journal of Urology CrossRef
10. Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
    Nazanin Momeni Roudsari et al, 2021, Pharmaceutics CrossRef